Advertisement
Loading...

Eisai Co., Ltd.

ESAIYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$6.17
$-0.10(-1.67%)
U.S. Market is Open • 14:09
Advertisement

Eisai Co., Ltd. (ESAIY) Stock Competitors & Peer Comparison

See (ESAIY) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ESAIY$6.18-4.92%7B28.09$0.22+3.24%
MKGAF$155.43+2.70%67.6B22.92$6.78+1.66%
MKKGY$29.76-0.27%65B22.14$1.35+1.73%
IPSEY$46.94-3.73%62.1B30.28$1.55+0.85%
TKPHF$32.10-1.53%50.7B42.80$0.75+4.06%
HLNCF$4.60-3.77%40.9B18.46$0.25+2.07%
SDZNY$82.76+0.88%35.8B39.61$2.09+1.23%
TEVJF$30.19+0.00%35.2B24.95$1.21N/A
TAIPY$14.00+16.67%18.1B82.35$0.17N/A
ESALY$61.51-2.11%17.6B20.54$3.00N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ESAIY vs MKGAF Comparison May 2026

ESAIY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ESAIY stands at 7B. In comparison, MKGAF has a market cap of 67.6B. Regarding current trading prices, ESAIY is priced at $6.18, while MKGAF trades at $155.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ESAIY currently has a P/E ratio of 28.09, whereas MKGAF's P/E ratio is 22.92. In terms of profitability, ESAIY's ROE is +0.04%, compared to MKGAF's ROE of +0.08%. Regarding short-term risk, ESAIY is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for ESAIY.Check MKGAF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions